埃布斯坦异常的治疗策略:在三十年的观察性研究
Peter Murin1,2,3, Victoria Lorenzen4,2, Olga Romanchenko1,2
1Department of Congenital Heart Surgery-Pediatric Heart Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany.
Interdisciplinary cardiovascular and thoracic surgery
|December 19, 2025
概括
对埃布斯坦异常的个性化手术方法,优先考虑早期干预,以形修复和双向格伦 (BDG) 程序,显著改善了患者的生存率. 这一策略将治疗量身定制到个体患者的需要,从而提高长期的治疗效果.
科学领域:
- 心血管外科心血管外科
- 遗传性心脏病是一种先天性心脏病.
- 儿童心脏病学 儿童心脏病学
背景情况:
- 埃布斯坦异常是一种罕见的先天性心脏缺陷,影响三管.
- 手术管理旨在纠正解剖异常并改善右心室功能.
- 从历史上看,结果各不相同,这促使人们对优化手术策略进行研究.
研究的目的:
- 为了比较埃布斯坦异常的长期手术结果,在实施个性化方法之前和之后.
- 评估早期干预,形修复和双向格伦 (BDG) 程序对生存的影响.
- 确定影响手术治疗埃布斯坦异常患者死亡率的风险因素.
主要方法:
- 在1988年至2022年间,对141名接受手术的患者进行了回顾性单中心分析.
- 在2012年之前 (标准护理) 和2012年之后 (个性化方法) 进行手术的患者之间的结局比较.
- 使用Kaplan-Meier估计和受限平均存活时间 (RMST) 的生存分析;用于风险因素识别的Cox回归.
主要成果:
- 个性化方法组 (2012年后) 较年轻,更频繁地接受形修复 +/- BDG.
- 五年生存率在2012年后显著改善,达到98.5%,与之前的时期相比 (81.7%至90%).
- 卡蒂尔分类 > B型和手术后败血症是死亡风险因素;圆修复没有增加风险,而BDG与较低的死亡率有关.
结论:
- 一个个性化的手术策略,强调早期干预与形修复和BDG,与改善的生存率在埃布斯坦的异常有关.
- 根据个体解剖学和血液动力学状况量身定制手术技术对于优化患者的治疗结果至关重要.
- 这些发现支持对埃布斯坦异常进行个性化手术治疗,以提高长期存活率.
相关概念视频
01:26Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
01:18Endocarditis III: Medical Management
197
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197
01:22Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
01:25Mitral Regurgitation III: Medical Management
253
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253
01:25Aortic Regurgitation III: Medical Management
373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373